- £9.48m
- £9.37m
- -£2.19m
- 51
- 59
- 46
- 50
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.087 | -0.162 | 3.24 | -1.57 | -2.19 |
Selling / General / Administrative Expenses | |||||
Other Operating Expenses | |||||
Total Operating Expenses | -0.159 | 0.151 | 0.153 | 0.16 | 0.182 |
Operating Profit | 0.246 | -0.313 | 3.08 | -1.73 | -2.37 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 0.257 | -0.303 | 3.09 | -1.73 | -2.37 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.257 | -0.303 | 3.09 | -1.73 | -2.37 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.257 | -0.303 | 3.09 | -1.73 | -2.37 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.257 | -0.303 | 3.09 | -1.73 | -2.37 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.003 | -0.003 | 0.033 | -0.012 | -0.016 |